Reactions 1680, p123 - 2 Dec 2017 Moderate impairment of cardiac contractibility: case report In a single institution long-term prospective study, a patient [age and sex not stated] was described, who developed moderate impairment of cardiac contractibility during treatment with doxorubicin [duration of treatment to reaction onset not stated]. The patient, who was newly diagnosed with Hodgkin lymphoma, started receiving chemotherapy with ABVD regimen that included IV doxorubicin 25 mg/m for days 1 and 15. Subsequently, the patient developed moderate impairment of cardiac contractibility. The patient was treated with carvedilol and a favourable outcome was achieved. Author comment: "The cumulative dose of doxorubicin raises concern on cardiac contractility in the long term, but if [radiotherapy] is avoided the potentiation of this late effect is reduced." "Other incidental complications were . . .moderate impairment of cardiac contractibility (1 patient treated with carvedilol with favorable outcome)". Zubizarreta PA, et al. Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy. Journal of Pediatric Hematology/Oncology 39: 602-608, No. 8, Nov 2017. Available from: URL: http://doi.org/10.1097/MPH.0000000000000943 - Argentina 803285521 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera